What development phase is Nausidol in?

Nausidol is FDA-approved (marketed).

What is the generic name of Nausidol?

PIPAMAZINE is the generic (nonproprietary) name of Nausidol.

Last reviewed 2026-04-20 · How we verify

Nausidol (PIPAMAZINE)

FDA-approved withdrawn Small molecule Quality 10/100

At a glance

Generic name	PIPAMAZINE
Drug class	pipamazine
Target	5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Nausidol CI brief — competitive landscape report
Nausidol updates RSS · CI watch RSS